يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Rechallenge anti‐EGFR"', وقت الاستعلام: 1.05s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Skin toxicity as predictor of survival in refractory patients with ras wild‐type metastatic colorectal cancer treated with cetuximab and avelumab (Cave) as rechallenge strategy

    المؤلفون: Ciardiello D., Famiglietti V., Napolitano S., Esposito L., Normanno N., Avallone A., Latiano T., Maiello E., Pietrantonio F., Cremolini C., Santabarbara G., Pinto C., Troiani T., Martinelli E., Ciardiello F., Martini G.

    المساهمون: Ciardiello, D., Famiglietti, V., Napolitano, S., Esposito, L., Normanno, N., Avallone, A., Latiano, T., Maiello, E., Pietrantonio, F., Cremolini, C., Santabarbara, G., Pinto, C., Troiani, T., Martinelli, E., Ciardiello, F., Martini, G.

    مصطلحات موضوعية: Immunotherapy, MCRC, Rechallenge anti‐EGFR, Skin toxicity

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34830870; info:eu-repo/semantics/altIdentifier/wos/WOS:000723622100001; volume:13; issue:22; numberofpages:12; journal:CANCERS; https://hdl.handle.net/11568/1113672Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118929902; https://www.mdpi.com/2072-6694/13/22/5715Test

    الإتاحة: https://doi.org/10.3390/cancers13225715Test
    https://hdl.handle.net/11568/1113672Test
    https://www.mdpi.com/2072-6694/13/22/5715Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy

    المؤلفون: Davide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, Lucia Esposito, Nicola Normanno, Antonio Avallone, Tiziana Latiano, Evaristo Maiello, Filippo Pietrantonio, Chiara Cremolini, Giuseppe Santabarbara, Carmine Pinto, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello, Giulia Martini

    المصدر: Cancers; Volume 13; Issue 22; Pages: 5715

    مصطلحات موضوعية: rechallenge anti-EGFR, immunotherapy, skin toxicity, mCRC

    وصف الملف: application/pdf

    العلاقة: https://dx.doi.org/10.3390/cancers13225715Test

    الإتاحة: https://doi.org/10.3390/cancers13225715Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Skin Toxicity as Predictor of Survival in Refractory Patients with RAS Wild-Type Metastatic Colorectal Cancer Treated with Cetuximab and Avelumab (CAVE) as Rechallenge Strategy

    المؤلفون: Erika Martinelli, Teresa Troiani, Lucia Esposito, Nicola Normanno, Davide Ciardiello, Carmine Pinto, Evaristo Maiello, Chiara Cremolini, Tiziana Latiano, Vincenzo Famiglietti, Giuseppe Santabarbara, Giulia Martini, Antonio Avallone, Stefania Napolitano, Fortunato Ciardiello, Filippo Pietrantonio

    المساهمون: Ciardiello, D., Famiglietti, V., Napolitano, S., Esposito, L., Normanno, N., Avallone, A., Latiano, T., Maiello, E., Pietrantonio, F., Cremolini, C., Santabarbara, G., Pinto, C., Troiani, T., Martinelli, E., Ciardiello, F., Martini, G.

    المصدر: Cancers
    Volume 13
    Issue 22
    Cancers, Vol 13, Iss 5715, p 5715 (2021)

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, Colorectal cancer, medicine.medical_treatment, Gastroenterology, Article, Refractory, Statistical significance, Internal medicine, Medicine, RC254-282, Chemotherapy, Univariate analysis, Cetuximab, business.industry, Hazard ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, skin toxicity, Rechallenge anti‐EGFR, Oncology, mCRC, rechallenge anti-EGFR, Biomarker (medicine), Immunotherapy, MCRC, Skin toxicity, immunotherapy, business, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e55445cfc7d6141ad784f6af82ce301bTest
    http://europepmc.org/articles/PMC8616320Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث